ENP Newswire -
Release date- 06062014 -
This is BD's sixth annual Sustainability Report, highlighting progress in the past year.
'The healthcare sector is in a period of great transition. We know this means that we will be faced with significant challenges and opportunities in the future,' said
BD's 2013 Sustainability Report highlights strategic priorities and performance in five key areas of sustainability:
Addressing Unmet Health Needs: BD announced a commitment to develop, manufacture and launch the Odon Device, an innovative new obstetrical instrument for assisting the delivery of newborns during circumstances of troublesome labor. BD will utilize its core competencies to establish low-cost production and offer affordable access pricing in developing countries.
Ensuring Good Governance and Ethics: In 2013, BD reinforced its implementation of its 'Doing What is Right' compliance training, and strengthened its signature anti-corruption program, Project Compass.
Safeguarding Product Safety and Performance: BD expanded its portfolio of safety products in 2013 by launching BD SimplistTM, a line of prefilled injectables, as well as acquiring Cato Software Solutions to increase accuracy in hospital pharmacies by supporting a more streamlined workflow.
Protecting the Environment: By concentrating environmental sustainability efforts on reducing the impact of its operations and products, by the end of fiscal 2013, BD had reached 80 percent of its 2015 sustainability targets. Key initiatives such as its wind energy project in
Making BD an
The sustainability report aligns with version 3.1 of the Global Reporting Initiative (GRI) guidelines, and has been self-assessed at GRI application level B.
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, supporting the management of diabetes and advancing cellular research.
We are nearly 30,000 associates in 50 countries who strive to fulfill our purpose of 'Helping all people live healthy lives' by advancing the quality, accessibility, safety and affordability of healthcare around the world.
Tel: (201) 847-4312
Most Popular Stories
- Homeowners More Satisfied With Mortgage Servicers
- Discounts Help U.S. Auto Sales Sizzle in July
- Russia, Ukraine Now Face Off Over Football Clubs
- Colorado Issuing Immigrant Driver's Licenses
- Recruiting and Keeping the Perfect Employee
- MassMutual Teams Up With ALPFA
- Chrysler U.S. Sales in July Hit 9-Year High
- Fiat Looks Abroad After Chrysler Merger Vote
- Dow Wipes Out Gains for the Year: What Happens Now?
- House Shelves Immigration Bill, Goes on Vacation